Please login to the form below

Not currently logged in
Email:
Password:

Merck's chair retires

Richard T Clark, chair of Merck (known as MSD outside the US and Canada) is to retire from the pharmaceutical company on December 1, 2011

Richard T Clark - MerckRichard T Clark, chair of Merck (known as MSD outside the US and Canada) is to retire from the pharmaceutical company on December 1, 2011.

He will be replaced by current CEO, Kenneth C Frazier who was elected by the board of directors.

Clark joined Merck in 1972 as a quality control inspector, and became chair in 2010. Other roles during his time at the company include president and CEO from 2005 to 2010, senior vice president of quality and commercial affairs, and president of the company's manufacturing division.

He said: "I have been a part of Merck for more than 39 years – I always have and always will consider Merck to be an important part of my life and my extended family. It has been a great pleasure to work with the talented, dedicated people of Merck who are so committed to our mission of saving and improving lives around the world."

During his time as CEO, Clark oversaw the successful launches of HIV treatment Isentress (raltegravir) and the HPV vaccine Gardasil.

He also led the company's $49bn merger with Schering-Plough in 2009.

10th October 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...

Infographics